Biliary Catheters Market - Global Forecast 2025-2032

The biliary catheters market is undergoing rapid transformation, with technology advances and evolving clinical requirements fostering innovative, patient-centric solutions. This report offers senior leaders the strategic insights needed to make informed decisions in a highly dynamic healthcare segment.

Market Snapshot: Strategic Momentum in the Biliary Catheters Market

The biliary catheters market grew from USD 2.00 billion in 2024 to USD 2.12 billion in 2025. It is expected to continue growing at a CAGR of 6.58%, reaching USD 3.33 billion by 2032. The market’s expansion is driven by rising incidences of hepatobiliary disorders, an aging global population, and heightened demand for advanced therapeutic and diagnostic solutions that elevate clinical outcomes.

Biliary Catheters Market Scope & Segmentation

This report provides comprehensive analysis across product categories, materials, procedures, functions, clinical applications, and end-user settings, mapping both technological evolution and regional dynamics. The segmentation includes:

• Product Types: Double lumen biliary catheters, multi-lumen biliary catheters, single lumen biliary catheters.
• Material Types: Polyurethane biliary catheters, PVC (polyvinyl chloride) biliary catheters, silicone biliary catheters.
• Procedure Applications: Diagnostic biliary catheters, therapeutic biliary catheters.
• Functionalities: Drainage catheters, stent-placement catheters, stone removal catheters.
• Clinical Applications: Cholangiography procedures, hepatobiliary & gastroenterology interventions, oncology-related uses.
• End Users: Ambulatory surgical centers (ASCs), hospitals, specialized clinics.
• Regional Analysis: Americas (North America and Latin America), Europe, Middle East & Africa (including sub-regional profiles), and Asia-Pacific.
• Leading Companies Profiled: Abbott Laboratories, AngioDynamics, Inc., Asahi Intecc Co., Ltd., B. Braun Melsungen AG, Becton, Dickinson and Company, Beijing Lepu Medical Technology Co., Ltd., Boston Scientific Corporation, Cardinal Health, Inc., ConMed Corporation, Cook Medical Incorporated, Edwards Lifesciences Corporation, EndoChoice, Inc., Hanmi Medical Co., Ltd., Johnson & Johnson, JW Medical Corporation, Medinol Ltd., Medtronic, Inc., Merit Medical Systems, Inc., MicroPort Scientific Corporation, Nipro Corporation, Olympus Corporation, SMT Medical GmbH, Teleflex Incorporated.

Biliary Catheters Market Key Takeaways

• Innovation continues to redefine biliary catheter capabilities through integration with advanced imaging modalities, antimicrobial enhancements, and modular architectures.
• Healthcare providers increasingly demand solutions that optimize accuracy, reduce procedure times, and minimize infection risks while elevating patient comfort.
• Material science advancements enable greater flexibility, biocompatibility, and customization, addressing distinct needs in oncology, hepatobiliary medicine, and gastroenterology.
• Supply chain and procurement strategies are evolving, especially in response to policy changes, to improve resilience and cost transparency.
• Leading device manufacturers employ targeted acquisitions, regional partnerships, and portfolio diversification to accelerate market penetration and post-sales support.
• Segment-specific deployments vary in importance: ambulatory centers value speed and cost-effectiveness; hospitals seek multi-use versatility; clinics prioritize specialty fit.

Tariff Impact: Adaptation Across the Value Chain

Revised United States tariffs on medical device imports in 2025 have significantly altered cost structures and sourcing strategies. Manufacturers have responded by diversifying production, seeking tariff exemptions, and negotiating new supply agreements. These adjustments have led to steeper acquisition costs for healthcare providers, prompting contract renegotiations and heightened emphasis on supply chain agility.

Methodology & Data Sources

The research integrates structured interviews with interventional radiologists, gastroenterologists, procurement managers, and regulatory experts. Supplementary secondary research reviewed filings, patents, clinical trial data, and peer-reviewed literature. All findings were triangulated and validated through advisory panel oversight.

Why This Report Matters

• Delivers timely, actionable intelligence for executives navigating evolving clinical, technological, and policy landscapes within the biliary catheters market.
• Equips stakeholders with detailed segmentation and competitive analysis essential for growth strategy and operational resilience.
• Facilitates informed investment and partnership decisions based on proven market drivers and emerging trends.

Conclusion

This report enables leadership teams to anticipate market shifts, confidently assess risks, and strengthen positioning in the biliary catheters sector. Readers gain focused perspective on technology trends, regulatory changes, and regional differentiation to support strategic planning and value creation.